Harris SB - Search Results

1

Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree.

Connelly PW, Hanley AJ, Harris SB, Hegele RA, Zinman B. Connelly PW, et al. Among authors: harris sb. Int J Obes Relat Metab Disord. 2003 Mar;27(3):347-54. doi: 10.1038/sj.ijo.0802239. Int J Obes Relat Metab Disord. 2003. PMID: 12629562

2

Controlled outcome evaluation of the First Step Program: a daily physical activity intervention for individuals with type II diabetes.

Tudor-Locke C, Bell RC, Myers AM, Harris SB, Ecclestone NA, Lauzon N, Rodger NW. Tudor-Locke C, et al. Among authors: harris sb. Int J Obes Relat Metab Disord. 2004 Jan;28(1):113-9. doi: 10.1038/sj.ijo.0802485. Int J Obes Relat Metab Disord. 2004. PMID: 14569279 Clinical Trial.

3

Low dietary fiber and high protein intakes associated with newly diagnosed diabetes in a remote aboriginal community.

Wolever TM, Hamad S, Gittelsohn J, Gao J, Hanley AJ, Harris SB, Zinman B. Wolever TM, et al. Among authors: harris sb. Am J Clin Nutr. 1997 Dec;66(6):1470-4. doi: 10.1093/ajcn/66.6.1470. Am J Clin Nutr. 1997. PMID: 9394701

4

Synergism between mutant HNF1A and the metabolic syndrome in Oji-Cree Type 2 diabetes.

Pollex RL, Hanley AJ, Zinman B, Harris SB, Khan HM, Hegele RA. Pollex RL, et al. Among authors: harris sb. Diabet Med. 2005 Nov;22(11):1510-5. doi: 10.1111/j.1464-5491.2005.01697.x. Diabet Med. 2005. PMID: 16241915

5

Discordant effects on central obesity, hepatic insulin resistance, and alanine aminotransferase of low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance.

Retnakaran R, Ye C, Hanley AJ, Harris SB, Zinman B. Retnakaran R, et al. Among authors: harris sb. Diabetes Obes Metab. 2012 Jan;14(1):91-3. doi: 10.1111/j.1463-1326.2011.01481.x. Epub 2011 Nov 21. Diabetes Obes Metab. 2012. PMID: 21812893 Clinical Trial.

6

Utility of non-high-density lipoprotein cholesterol in assessing incident type 2 diabetes risk.

Ley SH, Harris SB, Connelly PW, Mamakeesick M, Gittelsohn J, Wolever TM, Hegele RA, Zinman B, Hanley AJ. Ley SH, et al. Among authors: harris sb. Diabetes Obes Metab. 2012 Sep;14(9):821-5. doi: 10.1111/j.1463-1326.2012.01607.x. Epub 2012 May 11. Diabetes Obes Metab. 2012. PMID: 22510237

7

Absence of association between genetic variation of the beta 3-adrenergic receptor and metabolic phenotypes in Oji-Cree.

Hegele RA, Harris SB, Hanley AJ, Azouz H, Connelly PW, Zinman B. Hegele RA, et al. Among authors: harris sb. Diabetes Care. 1998 May;21(5):851-4. doi: 10.2337/diacare.21.5.851. Diabetes Care. 1998. PMID: 9589254

8

Disparity between association and linkage analysis for HNF1A G319S in type 2 diabetes in Canadian Oji-Cree.

Hegele RA, Hanley AJ, Zinman B, Harris SB, Anderson CM. Hegele RA, et al. Among authors: harris sb. J Hum Genet. 2000;45(3):184-7. doi: 10.1007/s100380050208. J Hum Genet. 2000. PMID: 10807546

9

The private hepatocyte nuclear factor-1alpha G319S variant is associated with plasma lipoprotein variation in Canadian Oji-Cree.

Hegele RA, Cao H, Harris SB, Hanley AJ, Zinman B, Connelly PW. Hegele RA, et al. Among authors: harris sb. Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):217-22. doi: 10.1161/01.atv.20.1.217. Arterioscler Thromb Vasc Biol. 2000. PMID: 10634821

10

Genetic variation in paraoxonase-2 is associated with variation in plasma lipoproteins in Canadian Oji-Cree.

Hegele RA, Harris SB, Connelly PW, Hanley AJ, Tsui LC, Zinman B, Scherer SW. Hegele RA, et al. Among authors: harris sb. Clin Genet. 1998 Nov;54(5):394-9. doi: 10.1111/j.1399-0004.1998.tb03752.x. Clin Genet. 1998. PMID: 9842991

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results